CN113209226A - Traditional Chinese medicine composition for treating type I diabetes - Google Patents
Traditional Chinese medicine composition for treating type I diabetes Download PDFInfo
- Publication number
- CN113209226A CN113209226A CN202110542180.6A CN202110542180A CN113209226A CN 113209226 A CN113209226 A CN 113209226A CN 202110542180 A CN202110542180 A CN 202110542180A CN 113209226 A CN113209226 A CN 113209226A
- Authority
- CN
- China
- Prior art keywords
- parts
- diabetes
- traditional chinese
- chinese medicine
- treating type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 28
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 title claims abstract description 15
- 239000000203 mixture Substances 0.000 title claims description 8
- 235000013311 vegetables Nutrition 0.000 claims abstract description 7
- 241000717662 Clinopodium chinense Species 0.000 claims abstract description 6
- 229940079593 drug Drugs 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 241000380130 Ehrharta erecta Species 0.000 claims abstract description 5
- 241000158764 Murraya Species 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims description 5
- 240000001899 Murraya exotica Species 0.000 claims description 4
- 235000008766 Murraya exotica Nutrition 0.000 claims description 4
- 235000009696 Murraya paniculata Nutrition 0.000 claims description 4
- 240000001085 Trapa natans Species 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 235000009165 saligot Nutrition 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 7
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 208000002249 Diabetes Complications Diseases 0.000 abstract 1
- 206010012655 Diabetic complications Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 13
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
- 206010012601 diabetes mellitus Diseases 0.000 description 10
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000002641 glycemic effect Effects 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 235000003283 Pachira macrocarpa Nutrition 0.000 description 1
- 206010033627 Pancreatic injury Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000014364 Trapa natans Nutrition 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000000667 effect on insulin Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating type I diabetes, which is prepared from the following raw material medicines in parts by weight: 4-8 parts of perennial grass and all-Forsythia; 6-12 parts of murraya jasminorage; 10-20 parts of longlife vegetable and Clinopodium chinense by weight; 15-30 parts of rhombohedra hemsleyana. It is forbidden for pregnant women. The invention has the characteristics of obvious treatment effect, short treatment period, no toxic or side effect, effective prevention and treatment of diabetic complications and the like.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine for treating type I diabetes.
Background
Type i diabetes is a form of diabetes, also known as insulin dependent diabetes mellitus, and the condition of the patient usually occurs in childhood or adolescent. May be an autoimmune disease. In this case, the immune system of the body attacks the beta cells that produce insulin in vivo, eventually resulting in the failure of insulin production in vivo. Most patients do not achieve glycemic control and the better glycemic control, the greater the risk of hypoglycemia. Various acute and chronic complications are high. Patients need to inject exogenous insulin to control blood glucose in vivo.
Disclosure of Invention
The invention aims to improve the defects of the prior art and provide the traditional Chinese medicine composition for treating the type I diabetes, which can effectively improve or even eliminate the clinical symptoms of patients and has the characteristics of obvious treatment effect, short treatment period, no toxic or side effect and the like.
The traditional Chinese medicine considers that congenital endowment deficiency is the basic reason of the occurrence of diabetes, and acquired improper diet, emotional disorder, excessive sexual intercourse or over-taking of warm-dryness medicines and the like are the important conditions of the occurrence of diabetes. The occurrence and development of diabetes are related to the dysfunction of liver in smoothing flow of qi, which is the basic pathogenesis of diabetes. It is due to liver dysfunction as the initiating factor, which can lead to yin deficiency, dryness-heat, blood stasis and other pathological changes, resulting in diabetes.
The invention provides a traditional Chinese medicine for treating type I diabetes, which is prepared from the following raw material medicines in parts by weight: 4-8 parts of perennial grass and all-Forsythia; 6-12 parts of murraya jasminorage; 10-20 parts of longlife vegetable and Clinopodium chinense by weight; 15-30 parts of rhombohedra hemsleyana.
In a preferred embodiment, the traditional Chinese medicine composition for treating type I diabetes consists of the following raw material medicines in parts by weight: 8 parts of perennial grass and all-flower fern; 12 parts of murraya paniculata; 20 parts of longlife vegetable and Clinopodium chinense; 30 parts of water caltrop flower.
Wherein, growing grass: pungent and even. It enters liver and heart meridians. Promoting blood circulation and restoring menstrual flow. The long-growing grass has obvious improvement effect on insulin resistance; obviously reduce blood sugar and increase insulin concentration.
The longevity dish: a monosodium glutamate; cold in nature, entering the large intestine; the liver meridian; clearing away heat and toxic materials; cooling blood and stopping dysentery;
researches find that the longevity vegetable can promote insulin secretion of islet glands, regulate the glycometabolism process of a human body, reduce the blood sugar concentration, keep the blood sugar constant and obviously reduce the blood sugar.
All-flower: salty, warm and nontoxic. Enter lung, liver and stomach meridians. Dissolve phlegm, descend qi, soften hardness and move water. Researches find that the all-Formosa flowers have a protective effect on pancreatic injury caused by diabetes, increase insulin and obviously reduce blood sugar.
The wind wheel vegetable: 2, pungent taste; bitter; is cool in nature. Dispelling wind and clearing heat; detoxication and detumescence; stopping bleeding. Researches show that the Clinopodium chinense nakai can obviously reduce blood sugar, reduce hepatic glycogen decomposition, increase hepatic glycogen synthesis and improve the lipid peroxidation resistance of organisms so as to relieve islet cell injury.
Water chestnut flower: is bitter in taste; is cold in nature. Large intestine, liver meridian. Clearing away heat and toxic materials; astringe to stop bleeding.
Researches find that the water caltrop flower can obviously reduce the blood sugar and obviously improve the insulin
Murraya paniculata (thunb.) repertoire: pungent, slightly bitter and warm in taste; has little toxicity. Move qi and alleviate pain, activate blood and dissipate blood stasis.
Researches find that the murraya paniculata can improve the blood lipid metabolism of diabetics, relieve inflammatory reaction and oxidative damage and improve the insulin secretion function.
The traditional Chinese medicine for effectively treating the type I diabetes is prepared from traditional Chinese herbal medicines, and is formed by orderly matching certain natural extracts with determined components and clear effects according to a plurality of principles of traditional Chinese medicine treatment based on syndrome differentiation and modern medicine.
The invention can run through the whole process of I-type diabetes treatment, the prescription is used for treatment, one dose of the prescription is taken every day, 100 ml of water is decocted by 150ml, the decoction is divided into two parts, one part is taken in the morning and at night, one month is taken as a treatment course, generally, one treatment course has effect, the three treatment courses can be obviously improved, the effect of treating I-type diabetes is obvious, the complications of diabetes are effectively prevented and treated, both the symptoms and root causes are treated, the medicine is safe and reliable, no obvious toxic or side reaction exists, the medicine is convenient for a patient to take for a long time, the patient does not have any adverse reaction after taking the medicine for many years, and the blood examination is tracked to be normal.
The traditional Chinese medicine composition has the advantages of easily available raw materials, simple process, low cost and high efficiency, and is beneficial to pharmaceutical enterprises for medicine production and quality control; the product has low price and is easy to be accepted by patients.
The invention also provides an oral preparation prepared from the traditional Chinese medicine composition for treating type I diabetes, which comprises oral liquid, tablets, capsules, pills and the like, preferably the dosage forms are tablets and capsules, and one dose is taken every day in the morning and at night.
The traditional Chinese medicine composition can be prepared into various dosage forms. For example, the decocted liquid medicine is sterilized and disinfected and then packaged to prepare oral liquid; or concentrating the decoction, oven drying, adding pharmaceutically acceptable adjuvants, and making into tablet, capsule, pill, etc.
The medically acceptable auxiliary materials comprise starch, dextrin, sodium carboxymethylcellulose, polyethylene glycol, calcium hydrophosphate, sodium alginate, potassium sorbate and the like.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the present invention in any way, and it will be apparent to those skilled in the art that the above description of the present invention can be applied to various modifications, equivalent variations or modifications without departing from the spirit and scope of the present invention.
Claims (4)
1. The traditional Chinese medicine for treating type I diabetes is characterized by comprising the following raw material medicines in parts by weight: 4-8 parts of perennial grass and all-Forsythia; 6-12 parts of murraya jasminorage; 10-20 parts of longlife vegetable and Clinopodium chinense by weight; 15-30 parts of rhombohedra hemsleyana.
2. The traditional Chinese medicine for treating type I diabetes as claimed in claim 1, which is characterized by comprising the following raw material medicines in parts by weight: 4-8 parts of perennial grass and all-Forsythia; 12 parts of murraya paniculata; 20 parts of longlife vegetable and Clinopodium chinense; 30 parts of water caltrop flower.
3. An oral preparation for treating type I diabetes, which is prepared from the traditional Chinese medicine composition of any one of claims 1 or 2.
4. The oral preparation for treating type I diabetes mellitus as claimed in claim 3, which comprises oral liquid, tablets, capsules and pills, preferably oral liquid and tablets.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010464298.7A CN111514243A (en) | 2020-05-28 | 2020-05-28 | Traditional Chinese medicine composition for treating type 1 diabetes |
| CN2020104642987 | 2020-05-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113209226A true CN113209226A (en) | 2021-08-06 |
Family
ID=71906717
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010464298.7A Pending CN111514243A (en) | 2020-05-28 | 2020-05-28 | Traditional Chinese medicine composition for treating type 1 diabetes |
| CN202110542180.6A Pending CN113209226A (en) | 2020-05-28 | 2021-05-19 | Traditional Chinese medicine composition for treating type I diabetes |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010464298.7A Pending CN111514243A (en) | 2020-05-28 | 2020-05-28 | Traditional Chinese medicine composition for treating type 1 diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN111514243A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111773280A (en) * | 2020-08-09 | 2020-10-16 | 仲崇允 | Traditional Chinese medicine composition for treating type I diabetes |
-
2020
- 2020-05-28 CN CN202010464298.7A patent/CN111514243A/en active Pending
-
2021
- 2021-05-19 CN CN202110542180.6A patent/CN113209226A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111773280A (en) * | 2020-08-09 | 2020-10-16 | 仲崇允 | Traditional Chinese medicine composition for treating type I diabetes |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111514243A (en) | 2020-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103156108B (en) | Fortified food for preventing and treating diabetes mellitus and hypertension diseases | |
| CN108524673A (en) | A kind of Chinese medicine composition and its application | |
| CN101822818B (en) | Composition of Chinese yam polysaccharide and Chinese yam protein and application thereof | |
| CN101543295A (en) | Health care tea for reducing blood pressure and blood fat | |
| CN1879802A (en) | Nutritious Chinese medicinal product for replenishing liver and kidney, resisting senility, decreasing blood fat, blood sugar and blood pressure and method for preparing same | |
| CN111773280A (en) | Traditional Chinese medicine composition for treating type I diabetes | |
| CN106692742A (en) | Traditional Chinese compound medicine for regulating blood sugar and preparation method of traditional Chinese compound medicine | |
| CN113209226A (en) | Traditional Chinese medicine composition for treating type I diabetes | |
| CN108403818A (en) | A kind of composition of auxiliary hyperglycemic and application thereof | |
| CN101564431B (en) | Chinese medicament preparation for keeping fit, resisting fatigue and fighting senium and producing method thereof | |
| CN105031248B (en) | It is a kind of containing selenium worm grass can auxiliary hyperglycemic health care product | |
| CN107712890A (en) | A kind of antitoxic heart-soothing and sedative cream taste and preparation method thereof | |
| CN113181258A (en) | A Chinese medicinal composition for treating menoxenia, dysmenorrhea, and amenorrhea | |
| CN103341073B (en) | Traditional Chinese medicine preparation for treatment of diabetes and preparation method thereof | |
| CN107029124B (en) | Traditional Chinese medicine composition for treating primary hypertension and preparation method thereof | |
| CN111529576A (en) | Traditional Chinese medicine composition for treating fatty liver | |
| CN111419970A (en) | Traditional Chinese medicine composition for treating myocarditis | |
| CN1267141C (en) | Method for preparing compound medicinal capsule and powder for nourishing yin | |
| CN105902867B (en) | A herbal composition for reducing hypertension, hyperglycemia and hyperlipidemia, and its preparation method | |
| CN104740345B (en) | Treat Chinese medicine composition of diabetes and preparation method thereof | |
| CN104413195A (en) | Eichhornia-crassipes blood-sugar-reducing tea and preparation method thereof | |
| CN109420039A (en) | A kind of Chinese medicine treated diabetes and merge hypoglycemia | |
| CN101053595B (en) | Medicinal preparation for treating constipation and its preparing method | |
| CN113244327A (en) | Traditional Chinese medicine composition for treating type II diabetes | |
| CN105943860A (en) | Medicine preparation for treating diabetes mellitus and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210806 |
|
| RJ01 | Rejection of invention patent application after publication |